![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Batm Advanced Communications Ld | LSE:BVC | London | Ordinary Share | IL0010849045 | ORD ILS0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.20 | -0.96% | 20.60 | 20.00 | 20.60 | 20.60 | 19.80 | 19.95 | 346,632 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Communications Services, Nec | 122.83M | -193k | -0.0004 | -500.00 | 90.7M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/1/2021 10:14 | Israel forced the price up at the open, but very little volumes in UK, so price is jumpy. | ![]() paulisi | |
08/1/2021 09:33 | Strange price movement this morning. On very low volume it jumped to 96 then down to 93 then up to 96 and down to just below 93. | ![]() car1pet | |
07/1/2021 09:02 | Nellyb Your message is blank | ![]() car1pet | |
07/1/2021 08:08 | sorry/deleted. | ![]() nellyb | |
06/1/2021 23:18 | interesting posts, thank you all. Chart looking poised to perhaps breakout from downtrend from the July high to now. | ![]() dibbs | |
06/1/2021 19:04 | If not, BATM should delist TASE and list on NASDAQ. Given the markets are sweet on good healthcare, incl Covid, and tech stocks, both BATM's business models, the share price performance has been rather pedestrian of late. I know it's ZVI's style to concentrate on the business but I wonder if a younger, more dynamic CEO could be found to promote both? | ![]() cumnor | |
06/1/2021 18:50 | Israel to buy 100k kits for FAST detection coronavirus that can detect the British virus. Could it be BATM? | ![]() wizzkid211 | |
05/1/2021 19:17 | FWIW I did not get the impression that it was a deal as such but that after running successful POC they were co operating on upgrading UCPE (white boxes) which are now being deployed. For any doubters !!! The above link is from ARM site on the Vodafone business. " Telco Systems platform complement’s the hardware efficiency by enabling a tightly integrated virtualization platform supporting a mix of containerized applications and NFV" Heres Telco systems version as it pertains to them. Finally an independent viewpoint detailing the significance of this alliance. The POC was completed. " Vodafone completed a Proof of Concept (POC) uCPE trial lead by Telco Systems and supported by partners Arm and NXP Semiconductor. " As far as I understand the Asian business is nothing to do with Vodafone/ARM/Telco. The Asian company are using an Intel platform and are deploying NVFTime on their UCPE NFVTime will run on Intel and ARM architecture and is apparently the only solution that will do so. This in turn means companies do not have to trash existing equipment and in many cases can integrate the new in with the old. It would have a considerably more cost effective outcome. | ![]() fse | |
05/1/2021 11:58 | They announced a POC with Vodafone and others after Vodafone released it and they announced a contract with a tier 1 customer based in Asia.We assume they are different, but are they? We have no feedback on the other 4 tier 1 customers who did POC testing. | ![]() paulisi | |
05/1/2021 07:12 | "as part of which a deal was signed with the giant Vodafone this year" ..... Haven't seen anywhere "A Deal" being signed with Vodafone. We know there was a POC completed successfully .... but haven't seen a deal as such. | ![]() rawdeal1 | |
04/1/2021 16:03 | Heres a slightly better translation from Hebrew from Wizz post above. Good spot. Looks like he is in the running for another business award. Of interest to shareholders is the comment that they don't need the money at the moment although he does not rule out a float on NASDAQ probably split off Telco. I cant see any reason for listing the medical side as its an amalgamation of several divisions that operate autonomously albeit in related fields. BATM founder and CEO, Dr. Zvi Marom, who made headlines this year with the corona tests he developed, reveals in an interview with BizPortal's People of the Year project that the company does not rule out a spin-off on NASDAQ and warns: "We treat viruses and other pathogens as a matter of routine, and as soon as we saw the corona virus spread we began to develop a range of diagnostic components needed to deal with the epidemic" - describes Dr. Zvi Marom, co-founder and CEO of Batm + 0.07%, how the company identified in time A real opportunity that has largely led to a more than 100% increase in its share price this year.Marom is one of BizPortal's system choices in BizPortal's People of the Year project for 2020, in which surfers will vote this week. Watch the full interview: "We did not go to Nasdaq because we do not need money at the moment," Marom explains why the company is not applying for an IPO on Wall Street. "At the moment, our shareholders are satisfied. It may be that in the future, if we spin parts of the company, we will also go to Nasdaq, During the interview, Marom says that the business environment in Israel has improved, but claims that "at the same time as exits, we should try to build strong local companies. "Unfortunately, most of the large manufacturing companies in Israel are foreign-owned, and it is dangerous because tomorrow morning an unnamed president of a company may decide to move the company to another location." Marom also warns against the escape of productive activity from Israel. "There is a double problem: both the size of the Israeli market, which must be export-oriented, and the government, which does not place any emphasis on the manufacturing sector." Marom noted that the corona kits developed by BATM also identify the British corona mutation, and will be able to identify the South African one and other mutations that may emerge in the future through various adjustments. "You could say in retrospect that we are reaping the rewards of a job we started a decade ago," says Marom, according to which the field of infectious diseases will continue to grow since "the corona goes nowhere - with and without the vaccine." In addition, Marom refers to BATM activities in the field of networking and cyber, as part of which a deal was signed with the giant Vodafone this year and the company enjoyed an increase in demand for wide network traffic due to moving from work in some workplaces and multimedia consumption during closures. Alongside these, Marom recounts how he rolled into the field, about his enjoyment of being involved in the development processes at BATM, about the many historical books he reads at home, about the friends from the world of culture and literature and the hobbies he cultivates in his spare time. | ![]() fse | |
04/1/2021 12:33 | from today's interview with dr. marom Batam's founder and CEO, Dr. Zvi Marom, who made headlines this year with the corona tests she developed, reveals in an interview with BizPortal's People of the Year project that the company does not rule out a spin-off at Nasdaq. "We did not go to Nasdaq because we do not need money at the moment," Marom explains why the company is not applying for an IPO on Wall Street. "At the moment, our shareholders are satisfied. It may be that in the future, if we spin parts of society, we will also go to the Nasdaq, but the appearance of our existence is not recruitment. we are thinking of a NASDAQ spinoff only for the good of the company | ![]() wizzkid211 | |
31/12/2020 17:11 | Usually we get a trading update in mid Jan with results about a month later. | ![]() paulisi | |
31/12/2020 16:22 | >hew.... NFV (Network functions vitualisation) was identified by Telco systems some years ago as a future standard for the industry. NFVTime is a sophisticated architecture employed in UCPE (Universal customer premise equipment) "white boxes" Telco systems NFVTime has the advantage of seamless architecture with both ARM and Intel platforms and the ability for scalability and introduction into existing networks. Often referred to as network orchestration. NFV is "now" considered an industry standard. 5G Networks will employ this standard so there is a lot to play for here. | ![]() fse | |
31/12/2020 12:05 | Wonder if news pended on a development from the below, from 17/8 Interims: “In addition, NFVTime is undergoing evaluation with several leading network operators and multi-service providers worldwide. These evaluations are at an advanced stage.” We have heard only of NFV incorporation in white goods AFAIK. | ![]() hew | |
31/12/2020 11:51 | Disappointing end to the year for BATM. No new order news and no announcement of divi. Lets hope 2021 is an improvement on 2020. Happy new year to everyone and stay at home tonight!!! | ![]() car1pet | |
31/12/2020 09:14 | Strange we haven't had a trading update for H2, just before year end..... as we had at end of June. Also still no mention of Dividend. | ![]() rawdeal1 | |
29/12/2020 17:51 | Disappointing drop, when the markets are rallying. | ![]() paulisi | |
28/12/2020 19:57 | NIPT screening is actually a really large business. For those of you who remember Vialogy/Premaitha/Yo Several countries will pay for NIPT testing and I believe it costs in the $550 per test range. The NIPT tests largely replaced amniosynthesis and the risks entailed albeit I am not sure what the diagnostic status is now..... | ![]() fse | |
28/12/2020 10:02 | The Twitter account is showcasing Zer Laboratories today, a subsidiary that never gets mentioned. Lots of testing, genetics, DNA stuff in there. | ![]() paulisi | |
28/12/2020 09:55 | Israel's rapid vaccine process is helped by a small population. They are expecting the over 60's to be done by end Jan and the majority of the population by end March. | ![]() paulisi | |
28/12/2020 09:12 | Israel I believe is back in lockdown | ![]() paulisi | |
27/12/2020 17:31 | Pretty flat on TASE today ... Israel has rolled out a rapid vaccination process so we should see what the results of that are sooner than anywhere else. Too bad the government still has not understood that achieving herd immunity is boosted by exposure to the virus with the healthier sector of the population ( ie younger) coupled with a vaccine will get them the numbers they need. Ironically the need, or the desire I should say, for testing to carry on is carrying on unabated. I would expect testing to be a mainstay of infectious disease management in the future.BATM rapid, accurate, constantly updated testing and "in situ" is a game changer for the future. The handling from food plants to airport testing is a comprehensive sensible set of tools available to Governments, should they choose to listen to the experts. I constantly hear politicians saying they are guided by science yet they censored any experts whose views contradicted their own agenda. Also infuriating are predictions of incredibly high numbers required to achieve full herd immunity. Its the same dodgy mathematical calculations done with no peer reviews that have already done so much damage. No one seems to want to comment on the seriousness (life threatening) nature of the the new strain which itself is only an "expected" mutation from the original variant which itself was only a variant of Coronavirus which has mutated since before the dawn of man. OMG. | ![]() fse | |
24/12/2020 16:38 | However, the current UK tests are detecting the variant otherwise the numbers would be significantly higher.Clever PR stunt. | ![]() paulisi | |
24/12/2020 15:41 | Nice Christmas present from BATM, best wishes to all for the holidays and hopes for a better connected/informed world. | ![]() fse |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions